Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,600+ categories llike Serum.

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo

Category Alerts


Thermo Fisher Expands Animal Origin Free Media Manufacturing Capacity

August 08, 2022
alert level: High

Pristine Biologicals Expands Production Capacity

July 14, 2022
alert level: Medium

Successful Transition of Cell Line Development With Animal Origin Component Free Media

July 27, 2022
alert level: Medium

Become a Beroe LiVE.Ai™ Subscriber to receive proactive alerts on Serum

Serum Market Monitoring Dashboard

Supply Demand

Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™

Serum Industry Benchmarks

Savings Achieved

(in %)

The average annual savings achieved in Serum category is 20.10%

Payment Terms

(in days)

The industry average payment terms in Serum category for the current quarter is 54.3 days

Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™

Category Strategy and Flexibility

Engagement Model

Supply Assurance

Sourcing Process

Supplier Type

Pricing Model

Contract Length


Lead Time

Supplier Diversity

Targeted Savings

Risk Mitigation

Financial Risk



Geopolitical Risk

Cost Optimization

Price per Unit Competitiveness

Specification Leanness

Minimum Order Quality

Payment Terms

Inventory Control

Meet Abi

The World’s first Digital Market Analyst

    Schedule a Demo
    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    Serum Suppliers

    Total Suppliers
    Diverse Suppliers
    Normalized Supplier Rating
    Serum Supplier

    Find the right-fit serum supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.

    Sample Supplier
    Catalent Inc.
    Jackson, Mississipi
    Duns number

    D&B SER Rating

    dnb logo

    Up to 3 months

    1 9
    Low Risk High Risk

    The Supplier Evaluation Risk (SER) Rating is Dun & Bradstreet’s proprietary scoring system used to assess the probability that a business will seek relief from creditors or cease operations within the next 12 months. SER ratings range from 1 to 9, with 9 indicating the highest risk of failure. We’ve prepared an infographic to help business owners better understand what influences their SER Rating.

    Moody`s ESG Solution
    ESG Profile

    Company and Sector Performance

    Limited (1)
    ESG Perfomance (/100)
    6 Domains Performance (/100)
    Business behaviour
    Human rights
    Community Environment
    Corporate governance
    Human resources
    Security Scorecard

    Threat indicators
    Network Security
    Detecting insecure network settings
    Hacker Chatter
    Monitoring hacker sites for chatter about your company
    DNS Health
    Detecting DNS insecure configuration and vulnerabilities
    Application Security
    Detecting common website application vulnerbilities
    Endpoint Security
    Detecting unprotected enpoints or entry points of user tools, such as desktops, laptops mobile devices, and virtual desktops
    Cubic Score
    Proprietary algorithms checking for implementation of common security best practices
    Patching Cadence
    Out of date company assets which may contain vulnerabilities of risk
    Social Engineering
    Measuring company awareness to a social engineering or phising attack
    IP Reputation
    Detecting suspecious activity, such as malware or spam, within your company network
    Information Leak
    Potentially confidential company information which may have been inadvertently leaked

    Industry Comparison
    Industry average
    Adverse Media Appearances
    Environmental Issues
    Workforce Health Safety Issues
    Product Service Issues
    Human Rights Issues
    Production Supply Chain Issues
    Environmental Non Compliance Flags
    Corruption Issues
    Regulatory Non Compliance Flags
    Fraud Issues
    Labor Health Safety Flags
    Regulatory Issues
    Workforce Disputes
    esg energy transition
    Discrimination Workforce Rights Issues
    esg controversies critical severity

    Serum Market Intelligence

    global market outlook

      • The global market size is 660,000 Liters in 2021 and the market is expected to grow at a CAGR of approx. 8–9 percent to 1077,000 liters by 2027
      • The APAC region is leading in the supply of FBS, limited demand exists for FBS in the Asian region. Several organizations in North America have been involved in the development of COVID-19 vaccines and drugs, which has increased the demand for FBS
      • Australia and New Zealand-origin serum or FBS are considered to be superior to other regions of origin. This is because of the low BSE or disease risk that these regions hold. However, the serum activity is found to be similar across all serums and other alternatives, like US-origin serum, can be considered.
      • The US-origin serum is also gaining more popularity ever since its upgrade to the negligible BSE risk category by OIE. Brazil or South American origin serum is considered as a low-cost alternative for the US-origin serum. Currently, it is more prevalent in the R&D segment than in manufacturing
      • Fetal bovine blood is the basic raw material used in the manufacture of Fetal Bovine Serum. The price of fetal bovine blood varies significantly due to various factors, such as herd rebuilding, drought, etc. This is the major cost component in the manufacturing of Fetal Bovine Serum

    Serum market frequently asked questions

    The worldwide serum supply in 2020 was around 704,000 L. As per Beroe’s category intelligence report, the global serum market will grow at 4-5% CAGR over the next five years, reaching nearly 899,000 L total volume.

    Rapid growth in the biopharmaceutical industry has been the primary driver for the global serum market. The fetal bovine serum (FBS) has been supplementing cell culture media for several decades. Furthermore, increasing demand from emerging regions, such as South Korea and other developing nations, will likely offer another leg of growth.

    While the US holds a significant revenue share in the global serum market, players prefer Australia and New Zealand for sourcing FBS owing to the lowest risk of transmissible spongiform encephalopathy (TSE) and bovine spongiform encephalopathy (BSE).

    Specific ethical, scientific, and supply challenges have compelled researchers to look for a substitute for FBS. Moreover, the supply of FBS is limited and is subject to various factors including, cattle cycles, beef demand, and weather patterns. Furthermore, issues with the supply chain monitoring of FBS are impacting manufacturers’ bottom lines.

    While there is a shift towards artificial serum, animal-based serums, especially FBS, find use in specific applications. Further, think tanks have dedicated several years to research in order to discover a substitute to FBS; however, they have yet to find a solid alternative.

    The US, Brazil, and Australia are the major serum producers worldwide. While the North American serum market is growing at a 4-5% CAGR, the market size in Europe is expanding at around 5% CAGR.

    Serum market report transcript

    Global Market Outlook on Serum 

    • Supply market for FBS is split across the US, Australia, Brazil, etc. The US contributes to the highest market share, which is greater than Australia and New Zealand

    • Dual sourcing of FBS is usually followed by major pharmaceutical companies for commercial manufacturing and R&D applications

    • Suppliers are evaluated for long-term supply assurance and traceability of serum

    • Usage of South American origin FBS has increased, particularly in the research community

    Impact of COVID-19 on FBS 

    • FBS supply and pricing are dependent on several factors, such as environmental, geopolitical, etc. Hence, the supply continuity and price stability may be inconsistent to an extent

    • Scientists have spent several years in research, trying to find an alternative to FBS, but there is no solid alternative till date

    Serum Market Overview 

    • Volume of FBS produced globally in 2020 is estimated to be around 704,000 L. The US, Australia, and Brazil are some of the major regions for FBS production.

    • The global FBS market is projected to grow at a rate of 4–5percent for the next five years and reach a total volume of nearly 899,000 L by 2025

    • New Zealand and Australia, having the lowest risk of BSE and TSE, are the most preferred locations for sourcing FBS

    • Increasing demand for FBS, coupled with slow growth in raw material fetal bovine blood (FBB), is one of the key challenges in the market

    • Although there is a shift toward artificial serum, there are certain applications for animal-based serum (especially, FBS), which cannot be overseen

    Industry Drivers and Constraints


    • Demand for FBS has been driven by the rapid growth in the biopharmaceutical industry. Cell culture media has been supplemented by FBS for many decades now

    • Demand from new regions, like South Korea and other developing countries, is expected to fuel the demand for FBS

    • FBS sourced from New Zealand and Australia are always preferred over any other serum, since they are free from any risk and assumed to offer better results


    • Due to the certain scientific, ethical and supply challenges, researchers have been forced to identify an alternative for FBS

    • Supply of FBB is finite and it often affected by factors, like weather pattern, dairy market, cattle cycles, and beef demand•Issues in traceability with the supply chain of FBS is a crucial factor that affects market growth